➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
McKesson
Boehringer Ingelheim
Medtronic
Mallinckrodt

Last Updated: September 22, 2021

DrugPatentWatch Database Preview

Investigational Drug Information for BMY-14802


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug BMY-14802?

BMY-14802 is an investigational drug.

There have been 8 clinical trials for BMY-14802. The most recent clinical trial was a Phase 2 trial.

The most common disease conditions in clinical trials are HIV Infections, AIDS-Related Complex, and Infection. The leading clinical trial sponsors are Bristol-Myers Squibb, National Institute of Allergy and Infectious Diseases (NIAID), and Northwestern University.

Recent Clinical Trials for BMY-14802
TitleSponsorPhase
Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial CancerNational Cancer Institute (NCI)Phase 2
Rebeccamycin Analogue in Treating Patients With Refractory Stage III or Stage IV Ovarian Epithelial CancerNorthwestern UniversityPhase 2
A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine TreatmentBristol-Myers SquibbPhase 2

See all BMY-14802 clinical trials

Clinical Trial Summary for BMY-14802

Top disease conditions for BMY-14802
Top clinical trial sponsors for BMY-14802

See all BMY-14802 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Merck
McKesson
Medtronic
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.